4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000236
EVP, Chief Development Officer sold 362 shares at $84.30 ($30,517)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kordasiewicz Holly B. EVP, Chief Development Officer | 2026-07-07 | Sale 10b5-1 | −362 | $84.30 | $30,517 | 22,096 | D: show line 1 in the form |
| Open-market sales · 362 sh · avg $84.30 · $30,517 | |||||||
Loading xslF345X06/edgardoc.xml…